BioSpace News Archive

Drug Development

Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) in Treatment of Patients with Vascular Trauma

Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.

September 12, 2023

·

9 min read

Business

Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World

Ceres Nanosciences and Ginkgo Bioworks announced that they are partnering to bring pathogen monitoring capabilities to laboratories around the world.

September 12, 2023

·

6 min read

Biotech Beach

Ionis to host investor and analyst day event

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host an investor and analyst day on Wednesday, October 4.

September 12, 2023

·

1 min read

Genetown

Olympus Adopts AcuityMD Across the Enterprise to Power an Expanding Omnichannel Engagement Strategy

AcuityMD has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals.

September 12, 2023

·

3 min read

Biotech Beach

Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases

Arialys Therapeutics, a biotechnology company pioneering new therapeutics for autoimmune neuropsychiatry, today announced the close of $58 million in seed financing.

September 12, 2023

·

3 min read

Genetown

ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension to Support Advancement of Lead Program into Clinical Development for Autoimmune Disease

ROME Therapeutics today announced the completion of an oversubscribed $72 million Series B extension financing, bringing the total Series B amount raised to $149 million.

September 12, 2023

·

3 min read

MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies

MaaT Pharma and Skyepharma announced that a significant development milestone has been reached with the completion of the facility and the transfer of MaaT Pharma’s Production and Development teams to the new site.

September 12, 2023

·

6 min read

Drug Development

Beactica Therapeutics strengthens its preclinical development team

Beactica Therapeutics AB, the Swedish precision oncology company, announced two appointments to its preclinical development team.

September 12, 2023

·

3 min read

Relu® reaches medical quality standards with ISO13485 certification

Relu, an OEM software provider in the dental industry, obtains ISO13485 certification from EU Notified Body Kiwa Dare.

September 12, 2023

·

1 min read

Drug Development

AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia

AlgoTherapeutix announces it has dosed the first patients of up to 14, in the US and European centers of its phase II proof of concept trial, called EASE*.

September 12, 2023

·

4 min read